Beyond immune cell interactions, secreted succinate from tumor cells binds to endothelial cell SUCNR-1, activating downstream STAT3-ERK1/2 in a HIF-independent manner and subsequently upregulating VEGF, thereby fostering angiogenesis. This evidence concerns the gene SUCNR1 and neoplasm.